Subdiaphragmatic extranodal localizations at diagnosis of primary mediastinal large B-cell lymphoma: an impressive, rare presentation with no independent effect on prognosis-Reference-Cited by-同舟云学术

Subdiaphragmatic extranodal localizations at diagnosis of primary mediastinal large B-cell lymphoma: an impressive, rare presentation with no independent effect on prognosis

Published:2021-08 Issue: Volume:107 Page:106595
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Karakatsanis Stamatis^ORCID,Papageorgiou Sotirios G.,Michail Michail,Angelopoulou Maria K.,Kalpadakis Christina,Leonidopoulou Theoni,Katodritou Eirini,Kotsopoulou Maria,Kotsianidis Ioannis,Hatzimichael Eleftheria,Lakiotaki Eleftheria,Boutsis Dimitrios,Karianakis George,Symeonidis Argiris,Gavriatopoulou Maria,Panayiotidis Panayiotis,Konstantopoulos Kostas,Karmiris Themis,Pangalis Gerassimos A.,Vassilakopoulos Theodoros P.^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference15 articles.

1. Primary mediastinal B-cell lymphoma;Boleti;Hematol. Oncol.,2007

2. Primary mediastinal large B-cell lymphoma: optimal therapy and prognostic factor analysis in 141 consecutive patients treated at Memorial Sloan Kettering from 1980 to 1999;Hamlin;Br. J. Haematol.,2005

3. International Extranodal Lymphoma Study Group (IELSG). Induction chemotherapy strategies for primary mediastinal large B-cell lymphoma with sclerosis: a retrospective multinational study on 426 previously untreated patients;Zinzani;Haematologica,2002

4. Gastric involvement in patients with primary mediastinal large B-cell lymphoma;Papageorgiou;Anticancer Res.,2014

5. Primary mediastinal lymphoma: diagnosis and treatment options;Martelli;Expert Rev. Hematol.,2015

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relapse of primary mediastinal B-cell lymphoma with isolated central nervous system involvement: risk factors and search for personalized therapy;P.A. Herzen Journal of Oncology;2024

2. Incidence and risk factors for central nervous system relapse in patients with primary mediastinal large B‐cell lymphoma in the rituximab era;Hematological Oncology;2022-12-08

3. Symptomatic ovarian involvement as the initial presentation of primary mediastinal large b-cell lymphoma;Gynecologic Oncology Reports;2022-06

4. Identification of Very Low-Risk Subgroups of Patients with Primary Mediastinal Large B-Cell Lymphoma Treated with R-CHOP;The Oncologist;2021-06-17